Week In Review: Adagene Forms $2.5 Billion, Four-Drug Partnership With Sanofi

Adagene will apply its technology to as many as four Sanofi candidates in a collaboration worth up to $2.5 billion. Huadong Medicine will acquire Asia rights for two Heidelberg Pharma ADC candidates in a deal potentially worth more than $1 billion.